Profile
Robert W.
Lehman is Director at EOM Pharmaceuticals Holdings, Inc. since 2022.
Formerly, Mr. Lehman was Chief Financial Officer at Western Asset Mortgage Capital Corp.
from 2022 to 2023, Senior Partner at Ernst & Young LLP from 1995 to 2021, and Independent Director at ImmunoCellular Therapeutics Ltd. Mr. Lehman completed undergraduate studies at Queens College.
Robert Lehman active positions
| Companies | Position | Start |
|---|---|---|
| EOM PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | 01/04/2022 |
Former positions of Robert Lehman
| Companies | Position | End |
|---|---|---|
| WESN ASSEPAR | Director of Finance/CFO | 06/12/2023 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Corporate Officer/Principal | 01/01/2021 |
| EOM PHARMACEUTICALS HOLDINGS, INC. | Director/Board Member | - |
Training of Robert Lehman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
ImmunoCellular Therapeutics Ltd.
ImmunoCellular Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage pharmaceutical company | Health Technology |
Western Asset Mortgage Capital Corp.
Western Asset Mortgage Capital Corp. Real Estate Investment TrustsFinance Functions as a real estate investment trust with a focus on residential and commercial mortgage markets | Finance |
Queens College
Queens College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EOM Pharmaceuticals Holdings, Inc.
EOM Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Robert Lehman
















